反应详情

To a solution of 2-[4-(tert-butyldimethylsilyloxy)phenyl]-N-[5-{4-(tert-butyldimethylsilyloxy)phenyl}-3-(naphthalen-1-yl)pyrazin-2-yl]acetamide (11d) (291 mg, 430 μmol) in THF (5 mL) was added tetrabutylammonium fluoride (1.0 M THF solution) (2.20 mL, 2.20 mmol) at 0° C. and the mixture was stirred for 30 minutes while elevating to room temperature. To the mixture was added saturated NH4Cl aqueous solution (50 mL) and the product was extracted with ethyl acetate (100 mL×3). The combined organic extract was washed successively with saturated NH4Cl aqueous solution (200 mL), water (200 mL) and brine (200 mL), followed by drying over anhydrous sodium sulfate. After filtration and concentration under reduced pressure, the residue was recrystallized (n-hexane/ethanol) to give Compound 4d (TMD-338) (181 mg, 404 μmol, 93.8%) as a brown solid. Rf=0.56 (dichloromethane/methanol=9/1); HPLC retention time 9.1 min; 1H NMR (400 MHz, DMSO-d6) δ 3.17 (s, 2H), 6.45-6.53 (AA′BB′, 2H), 6.56-6.64 (AA′BB′, 2H), 6.80-6.88 (AA′BB′, 2H), 7.35-7.56 (m, 4H), 7.61-7.68 (m, 1H), 7.88-8.04 (m, 4H, includes AA′BB′), 9.03 (s, 1l), 9.15 (s, 1H), 9.85 (s, 1H), 10.14 (s, 1H); 13C NMR (75.5 MHz, DMSO-d6) δ 41.2, 115.0 (2C), 115.9 (2C), 125.1, 125.3, 125.4, 125.8, 126.3, 126.5, 126.9, 128.25, 128.27 (2C), 128.7, 129.8 (2C), 130.7, 133.4, 134.9, 138.0, 144.0, 148.38, 148.44, 155.9, 159.2, 169.8; IR (KBr, cm−1) 492, 540, 623, 777, 802, 839, 982, 1078, 1171, 1231, 1317, 1364, 1447, 1477, 1516, 1609, 1670, 3055, 3246; HRMS (ESI+) m/z 470.1483 ([M+Na]+, C28H21N3NaO3+ requires 470.1475).

1. customwhile elevating to room temperature
2. extractionthe product was extracted with ethyl acetate (100 mL×3)
3. extractionThe combined organic extract
4. washwas washed successively with saturated NH4Cl aqueous solution (200 mL), water (200 mL) and brine (200 mL)
5. dry with materialby drying over anhydrous sodium sulfate
6. filtrationAfter filtration and concentration under reduced pressure
7. customthe residue was recrystallized (n-hexane/ethanol)